Literature DB >> 15572151

Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling.

Yasuhito Hayashi1, Chia-Yang Liu, James J Jester, Miyuki Hayashi, I-Jong Wang, James L Funderburgh, Shizuya Saika, Peter J Roughley, Candace Whei-Cheng Kao, Winston Whei-Yang Kao.   

Abstract

Tissue morphogenesis during development is regulated by growth factors and cytokines, and is characterized by constant remodeling of extracellular matrix (ECM) in response to signaling molecules, for example, growth factors, cytokines, and so forth. Proteoglycans that bind growth factors are potential regulators of tissue morphogenesis during embryonic development. In this study, we showed that transgenic mice overexpressing biglycan under the keratocan promoter exhibited exposure keratitis and premature eye opening from noninfectious eyelid ulceration due to perturbation of eyelid muscle formation and the failure of meibomian gland formation. In addition, in vitro analysis revealed that biglycan binds to TGF-alpha, thus interrupting EGFR signaling pathways essential for mesenchymal cell migration induced by eyelid epithelium. The defects of TGF-alpha signaling by excess biglycan were further augmented by the interruption of the autocrine or paracrine loop of the EGFR signaling pathway of HB-EGF expression elicited by TGF-alpha. These results are consistent with the notion that under physiological conditions, biglycan secreted by mesenchymal cells serves as a regulatory molecule for the formation of a TGF-alpha gradient serving as a morphogen of eyelid morphogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15572151      PMCID: PMC2876305          DOI: 10.1016/j.ydbio.2004.09.022

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  57 in total

1.  Complexes of matrilin-1 and biglycan or decorin connect collagen VI microfibrils to both collagen II and aggrecan.

Authors:  Charlotte Wiberg; Andreas R Klatt; Raimund Wagener; Mats Paulsson; John F Bateman; Dick Heinegård; Matthias Mörgelin
Journal:  J Biol Chem       Date:  2003-07-01       Impact factor: 5.157

2.  Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice.

Authors:  Juan Carlos Casar; Beth A McKechnie; Justin R Fallon; Marian F Young; Enrique Brandan
Journal:  Dev Biol       Date:  2004-04-15       Impact factor: 3.582

3.  Meibomian gland dysfunction. I. Keratin protein expression in normal human and rabbit meibomian glands.

Authors:  J V Jester; N Nicolaides; R E Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1989-05       Impact factor: 4.799

4.  Interaction of biglycan with type I collagen.

Authors:  E Schönherr; P Witsch-Prehm; B Harrach; H Robenek; J Rauterberg; H Kresse
Journal:  J Biol Chem       Date:  1995-02-10       Impact factor: 5.157

5.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

Authors:  A Hildebrand; M Romarís; L M Rasmussen; D Heinegård; D R Twardzik; W A Border; E Ruoslahti
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

6.  Biglycan, a vascular proteoglycan, binds differently to HDL2 and HDL3: role of apoE.

Authors:  K L Olin; S Potter-Perigo; P H Barrett; T N Wight; A Chait
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-01       Impact factor: 8.311

7.  Keratin 12-deficient mice have fragile corneal epithelia.

Authors:  W W Kao; C Y Liu; R L Converse; A Shiraishi; C W Kao; M Ishizaki; T Doetschman; J Duffy
Journal:  Invest Ophthalmol Vis Sci       Date:  1996-12       Impact factor: 4.799

8.  The cloning of mouse keratocan cDNA and genomic DNA and the characterization of its expression during eye development.

Authors:  C Y Liu; A Shiraishi; C W Kao; R L Converse; J L Funderburgh; L M Corpuz; G W Conrad; W W Kao
Journal:  J Biol Chem       Date:  1998-08-28       Impact factor: 5.157

9.  Localization of transforming growth factor beta binding site in betaglycan. Comparison with small extracellular matrix proteoglycans.

Authors:  D Fukushima; R Bützow; A Hildebrand; E Ruoslahti
Journal:  J Biol Chem       Date:  1993-10-25       Impact factor: 5.157

10.  Role of integrins in mouse eyelid development: studies in normal embryos and embryos in which there is a failure of eyelid fusion.

Authors:  J M Carroll; N C Luetteke; D C Lee; F M Watt
Journal:  Mech Dev       Date:  1998-11       Impact factor: 1.882

View more
  19 in total

Review 1.  The international workshop on meibomian gland dysfunction: report of the subcommittee on anatomy, physiology, and pathophysiology of the meibomian gland.

Authors:  Erich Knop; Nadja Knop; Thomas Millar; Hiroto Obata; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-03-30       Impact factor: 4.799

Review 2.  Role of EGF receptor signaling on morphogenesis of eyelid and meibomian glands.

Authors:  Fei Dong; Mindy Call; Ying Xia; Winston W-Y Kao
Journal:  Exp Eye Res       Date:  2017-10       Impact factor: 3.467

Review 3.  Biglycan in the Skeleton.

Authors:  Vardit Kram; Reut Shainer; Priyam Jani; Josephina A N Meester; Bart Loeys; Marian F Young
Journal:  J Histochem Cytochem       Date:  2020-07-06       Impact factor: 2.479

4.  Notch gain of function in mouse periocular mesenchyme downregulates FoxL2 and impairs eyelid levator muscle formation, leading to congenital blepharophimosis.

Authors:  Yujin Zhang; Winston W-Y Kao; Emanuele Pelosi; David Schlessinger; Chia-Yang Liu
Journal:  J Cell Sci       Date:  2011-07-05       Impact factor: 5.285

5.  Biglycan regulates the expression and sarcolemmal localization of dystrobrevin, syntrophin, and nNOS.

Authors:  Mary Lynn Mercado; Alison R Amenta; Hiroki Hagiwara; Michael S Rafii; Beatrice E Lechner; Rick T Owens; David J McQuillan; Stanley C Froehner; Justin R Fallon
Journal:  FASEB J       Date:  2006-06-28       Impact factor: 5.191

6.  Meibomian gland morphogenesis requires developmental eyelid closure and lid fusion.

Authors:  Jingjing Wang; Mindy Call; Maureen Mongan; Winston Whei-Yang Kao; Ying Xia
Journal:  Ocul Surf       Date:  2017-03-08       Impact factor: 5.033

7.  Changes in gene expression in human meibomian gland dysfunction.

Authors:  Shaohui Liu; Stephen M Richards; Kristine Lo; Mark Hatton; Aaron Fay; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-25       Impact factor: 4.799

Review 8.  Wakayama symposium: challenges of future research in ocular surface cell biology.

Authors:  Winston W-Y Kao; Hongshan Liu; Jianhua Zhang
Journal:  Ocul Surf       Date:  2012-07-25       Impact factor: 5.033

9.  Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).

Authors:  Daniela G Seidler; Muhammad Faiyaz-Ul-Haque; Uwe Hansen; George W Yip; Syed H E Zaidi; Ahmad S Teebi; Ludwig Kiesel; Martin Götte
Journal:  J Mol Med (Berl)       Date:  2006-04-01       Impact factor: 4.599

10.  Perturbed meibomian gland and tarsal plate morphogenesis by excess TGFα in eyelid stroma.

Authors:  Fei Dong; Chia-Yang Liu; Yong Yuan; Yujin Zhang; Wei Li; Mindy Call; Liyun Zhang; Yongxiong Chen; Zuguo Liu; Winston W Y Kao
Journal:  Dev Biol       Date:  2015-09-10       Impact factor: 3.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.